Form 4: Moderna President Stephen Hoge Reports Stock Transactions

Moderna's President, Stephen Hoge, reported the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Summary

• Stephen Hoge, President of Moderna, reported transactions involving Moderna's common stock.
• On November 8, 2024, 523 restricted stock units (RSUs) vested and converted into common stock.
• Also on November 8, 2024, Hoge acquired 523 shares.
• On November 11, 2024, Hoge sold 277 shares at a price of $46.1047 per share to cover tax withholding obligations related to the vesting of RSUs.
• Following these transactions, Hoge directly owns 1,443,248 shares of Moderna common stock.
• Hoge also indirectly owns 4,116 shares through Valhalla, LLC and 151,933 shares through a trust for the benefit of his spouse and children.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives of publicly traded companies. These transactions are often related to equity compensation plans and tax obligations.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the small number of shares involved compared to the total outstanding shares of Moderna.

Key Dates